“About 10 percent of the nation's physicians have signed up as consultants to the investment industry, according to the New York Times. There's nothing necessarily wrong with that except that some of these investors are looking for proprietary data on clinical trials that can affect their sponsors' valuations.”
So reports Health Business Blog, in two posts that quickly and comprehensively sum up some of the ethical issues of physicians serving two (incompatible) masters. Recommended.